Canada markets open in 4 hours 38 minutes

Editas Medicine, Inc. (EDIT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.67+0.05 (+0.89%)
At close: 04:00PM EDT
5.71 +0.04 (+0.72%)
After hours: 06:48PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 466.27M
Enterprise Value 179.70M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.51
Price/Book (mrq)1.34
Enterprise Value/Revenue 2.30
Enterprise Value/EBITDA -1.10

Trading Information

Stock Price History

Beta (5Y Monthly) 2.02
52-Week Change 3-41.58%
S&P500 52-Week Change 322.38%
52 Week High 311.91
52 Week Low 35.11
50-Day Moving Average 37.32
200-Day Moving Average 38.25

Share Statistics

Avg Vol (3 month) 31.96M
Avg Vol (10 day) 31.75M
Shares Outstanding 582.23M
Implied Shares Outstanding 682.23M
Float 876.15M
% Held by Insiders 10.32%
% Held by Institutions 180.31%
Shares Short (Apr 15, 2024) 418.76M
Short Ratio (Apr 15, 2024) 49.51
Short % of Float (Apr 15, 2024) 428.92%
Short % of Shares Outstanding (Apr 15, 2024) 422.81%
Shares Short (prior month Mar 15, 2024) 413.93M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -196.12%
Operating Margin (ttm)-39.90%

Management Effectiveness

Return on Assets (ttm)-20.87%
Return on Equity (ttm)-43.17%

Income Statement

Revenue (ttm)78.12M
Revenue Per Share (ttm)1.03
Quarterly Revenue Growth (yoy)818.70%
Gross Profit (ttm)N/A
EBITDA -163.12M
Net Income Avi to Common (ttm)-153.22M
Diluted EPS (ttm)-2.02
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)323.11M
Total Cash Per Share (mrq)3.95
Total Debt (mrq)36.54M
Total Debt/Equity (mrq)10.47%
Current Ratio (mrq)5.39
Book Value Per Share (mrq)4.27

Cash Flow Statement

Operating Cash Flow (ttm)-132.18M
Levered Free Cash Flow (ttm)-87.81M